Comparison of Ondansetron vs Haloperidol to prevent postoperative nausea and vomiting

Comparison of Ondansetron vs Haloperidol to prevent postoperative nausea and vomiting in patients undergoing surgery with general anesthesia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210926052586N1

Enrollment

Registered

2021-10-23

Start date

2021-10-23

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting. ???? ? ??????? ??? ?? ??? ?????

Interventions

Intervention 1: Intervention group: 15 mg of ondansetron is injected 15 minutes before the end of the surgery. Intervention 2: Intervention group: 15 mg of haloperidol is injected 15 minutes before th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: General anesthesia indication ASA 1,2 class Possibility of patient follow up at least 24h after surgery Patient satisfaction to participate in this research project

Exclusion criteria

Exclusion criteria: Advanced underlying disease Addiction Patient dissatisfaction to participate in this research project Motion Sickness Excessive bleeding during surgery Severe postoperative complication BMI>30

Design outcomes

Primary

Measure	Time frame
Comparison of the effect of ondansetron and haloperidol on postoperative nausea and vomiting. Timepoint: From recovery time to 24 hours after surgery. Method of measurement: Questionnaire number 1.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedmohammad Karimi

Islamic Azad University

smkarimi.md@gmail.com+98 21 2200 6660

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026